| 131I | iodine-131 |
| AHR | aryl hydrocarbon receptor |
| AI | artificial intelligence |
| AP1 | activator protein 1 |
| ATA | American Thyroid Association |
| ATC | anaplastic thyroid cancer |
| BMI | body mass index |
| CEA | carcinoembryonic antigen |
| CGRP | calcitonin gene-related peptide |
| CRP | C-reactive protein |
| CT | computed tomography |
| Ctn | calcitonin |
| DC | dendritic cell |
| DSS | disease-specific survival |
| DSV | diffuse sclerosing variant |
| DTC | differentiated thyroid cancer |
| EDCs | endocrine-disrupting chemicals |
| ERα | estrogen receptor alpha |
| ERβ | estrogen receptor beta |
| FMTC | familial medullary thyroid cancer |
| FNA | fine-needle aspiration |
| FNAB | fine-needle aspiration biopsy |
| FNAC | fine-needle aspiration cytology |
| FT3 | free triiodothyronine |
| FT4 | free thyroxine |
| FTC | follicular thyroid carcinoma |
| FTC | follicular thyroid cancer |
| FVPTC | follicular variant of papillary thyroid carcinoma |
| FVPTC | PTC with a dominant follicular variant |
| HDI | Human Development Index |
| HT | Hashimoto thyroiditis |
| HV | hobnail |
| IGF-1 | insulin-like growth factor 1 |
| LND | lymph node dissection |
| LNM | lymph node metastasis |
| MAPK | MAP kinase |
| MEN2 | multiple endocrine neoplasia type 2 |
| MEN4 | multiple endocrine neoplasia type 4 |
| MRI | magnetic resonance |
| MTC | medullary thyroid cancer |
| NF-kB | nuclear factor kappa-light-chain-enhancer of activated B |
| NIFTP | non-invasive follicular thyroid neoplasm with papillary-like nuclear features |
| NIS | sodium–iodide symporter |
| ORR | treatment response rate |
| OS | overall survival |
| PCR | reverse-transcriptase polymerase reaction |
| Pct | procalcitonin |
| PTC | papillary thyroid cancer |
| RAI | radioactive iodine |
| RF | radiofrequency |
| SHS | secondhand smoking |
| SPECT | single-proton emission computed tomography |
| SV | solid variant |
| T3 | triiodothyronine |
| T4 | thyroxine |
| TAMs | tumor-associated macrophages |
| TBG | thyroxine-binding globulin |
| TBSRTC | The Bethesda System for Reporting Thyroid Cytopathology |
| TC | thyroid cancer |
| TCV | tall cell variant |
| TG | thyroglobulin |
| TKIs | tyrosine kinase inhibitors |
| TME | tumor microenvironment |
| TNF | tumor necrosis factor |
| TSH | thyroid-stimulating hormone |
| TSHRs | TSH receptors |
| TT | total thyroidectomy |
| TgAb | anti-TG antibody |
| US | ultrasonography |
| VIP | vasoactive intestinal peptide |
| lncRNAs | long non-coding RNAs |
| mRNA | messenger RNA |
| miRNA | microRNA |